Home›Stock Screener›Ind Swift Laboratories›Quarterly Results

Ind Swift Laboratories Quarterly Results

Latest Quarter Net Profit
₹15 Cr
QMar 2026
Quarterly Results

Ind Swift Laboratories quarterly results. In Mar 2026, Ind Swift Laboratories (INDSWFTLAB) reported revenue ₹172 Cr and net profit ₹15 Cr — revenue -52.1% YoY. Review INDSWFTLAB P/E comparison to evaluate earnings-based valuation against sector peers.

INDSWFTLAB Quarterly Results — Revenue, Profit & EPS Highlights

Ind Swift Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check INDSWFTLAB company valuation to track the company's total market size over time.

  • Revenue of ₹172 Cr in Mar 2026 (-13.6% vs Jun 2026, -52.1% vs Mar 2025)
  • Net Profit of ₹15 Cr in Mar 2026 (-40.0% vs Jun 2026, -93.2% vs Mar 2025)
  • EBITDA of ₹18 Cr in Mar 2026 (-56.1% vs Jun 2026)
  • Operating Margin of 9.0% in Mar 2026 (-8.0pp vs Jun 2026)
  • Earnings Per Share of ₹1.81 in Mar 2026 (-36.3% vs Jun 2026)

Ind Swift Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

INDSWFTLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 172 199 171 359 167 -13.6% -52.1%
Net Profit (₹ Cr) 15 25 8 222 9 - -
EBITDA (₹ Cr) 18 41 19 211 18 - -
EPS (₹) 1.81 2.84 1.00 32.96 1.28 - -
Operating Margin (%) 9.0% 17.0% 1.0% -7.0% 2.0% - -

INDSWFTLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Ind Swift Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit INDSWFTLAB share price.

Profitability Ratios

Profit Margin 8.7%
EBITDA Margin 10.5%
Operating Margin 9.0%
ROE (Annual) 4.3%

Balance Sheet Highlights

Total Assets ₹1,673 Cr
Total Equity ₹1,384 Cr
Current Assets ₹977 Cr
Current Liabilities ₹32 Cr

Cash Flow Analysis

Operating Cash Flow ₹-68 Cr
Investing Cash Flow ₹-69 Cr
Financing Cash Flow ₹142 Cr
Net Cash Flow ₹5 Cr

Current Market Data

Current Price ₹385.75
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 359
Sept 2025 171
Jun 2026 199
Mar 2026 172

Net Profit Trend (₹ Cr)

Mar 2025 222
Sept 2025 8
Jun 2026 25
Mar 2026 15

Operating Margin Trend (%)

Mar 2025 -7.0%
Sept 2025 1.0%
Jun 2026 17.0%
Mar 2026 9.0%

INDSWFTLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Ind Swift Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores